In an announcement from Buckingham Palace on Monday, it was revealed that King Charles III, aged 75, has been diagnosed with an undisclosed form of cancer. While recently undergoing treatment for an enlarged prostate, the Palace clarified that the diagnosis does not relate to prostate cancer but was uncovered during subsequent health checks prompted by the prostate treatment.
The monarch initiated cancer treatment on Monday, resulting in the postponement of his royal engagements. Other senior family members are expected to take his place in these responsibilities. The Palace emphasized the King’s decision to disclose his illness to preempt speculation and promote public understanding, especially for those facing similar diagnoses.
In response to the news, Prince Harry has reportedly conversed with his father and plans to travel to the U.K. in the coming days. The King, having returned from Sandringham in Norfolk, is now in London for his initial cancer treatment.
This update follows a recent public focus on King Charles III’s health since his admission to a private London clinic hospital on January 26 for a pre-planned procedure addressing his enlarged prostate, also known as benign prostatic hyperplasia (BPH). As the monarch embarks on his cancer treatment, the public remains attentive to developments and wishes for his swift recovery.